Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis

Clinical trial NCT00146627 · COMPLETED

Trial details

NCT number: NCT00146627
Sponsor: Drugs for Neglected Diseases
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Trypanosomiasis, African

Primary completion: 2008-06-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.